Rahul Banerjee

Dr. Rahul Banerjee is a physician and researcher specializing in hematology and oncology, currently serving as an Assistant Professor at the Fred Hutchinson Cancer Center and the University of Washington. His clinical expertise includes multiple myeloma, AL amyloidosis, and CAR-T cell therapy for blood cancers. His research focuses on reducing the toxicity of cellular immunotherapies, improving the patient treatment experience, and optimizing the patient journey through digital health technologies. Dr. Banerjee is a member of the International Myeloma Working Group and has published over 120 peer-reviewed academic articles, making significant contributions to the field of hematology.

• 2022–Present·Fred Hutchinson Cancer Center·Assistant Professor
  • Working in the clinical research department, focusing on research and clinical practice in multiple myeloma and CAR-T therapy.
• 2022–Present·University of Washington·Assistant Professor
  • Teaching and researching hematology and oncology; involved in patient care and academic research.
• 2017–2018·Philadelphia VA Medical Center·Chief Resident in Internal Medicine
  • Managed quality improvement projects and supervised resident physician training.

• 2021–2022·University of California, San Francisco·Advanced Fellowship
  • Bone Marrow Transplant & Cellular Therapy
• 2018–2021·University of California, San Francisco·Fellowship
  • Hematology & Oncology
• 2017–2018·Philadelphia VA Medical Center·Chief Resident
  • Internal Medicine Quality Improvement
• 2014–2017·Hospital of the University of Pennsylvania·Residency
  • Internal Medicine
• 2010–2014·Warren Alpert Medical School of Brown University·Doctor of Medicine
• 2006–2010·Brown University·Bachelor's Degree (Honors)
  • Bachelor of Science